Below is information about APTALIS PHARMA HEADQUARTERS from a variety of sources. Please take a look at the materials that our team has selected for you.
https://www.dnb.com/business-directory/company-profiles.aptalis_pharma_us_inc.10905361bf21b510c909c58ec9219963.html
Company Description: Aptalis Pharma Us, Inc. is located in Bridgewater, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Aptalis Pharma Us, Inc. has 4 employees at this location. (Employees figure is modelled). There are 132 companies in the Aptalis Pharma Us, Inc. corporate family.
https://www.crunchbase.com/organization/aptalis
Headquarters Regions East Coast, Northeastern US; Founded Date 1982; Founders Frank Verwiel; Operating Status Active; Last Funding Type Seed; Also …
https://en.wikipedia.org/wiki/Aptalis
https://www.linkedin.com/company/aptalis-pharma
Aptalis Pharma is a pharmaceuticals company based out of 100 SOMERSET CORPORATE, BRIDGEWATER, New Jersey, United States. Website http://aptalispharma.mwnewsroom.com Industries Pharmaceuticals...
https://pitchbook.com/profiles/company/11058-85
Aptalis Pharma Comparisons Description Primary Industry HQ Location Employees Total Raised Post Valuation Last Financing Details Manufacturer of pharmaceutical products for the treatment of gastrointestinal diseases. The company offers therapies for Pharmaceuticals Bridgewater, NJ 875 As of 2014 000.00 0.00 0000-00-00 000000&0 000.00 00000 00
https://www.bloomberg.com/profile/company/1269821D:US
Company profile page for Aptalis Pharma US Inc including stock price, company news, press releases, executives, board members, and contact information
https://www.dnb.com/business-directory/company-profiles.aptalis_pharma_canada_ulc.eccd9859e322c0f616566dfcc5c3388c.html
Company Description: Aptalis Pharma Canada ULC is located in Mont-Saint-Hilaire, QC, Canada and is part of the Drugs and Druggists' Sundries Merchant Wholesalers Industry. Aptalis Pharma Canada ULC has 480 total employees across all of its locations and generates $198.15 million in sales (USD). (Sales figure is modelled).
April 26, 2022. Apellis Pharmaceuticals to Host Conference Call on May 4, 2022 to Discuss First Quarter 2022 Financial Results. Newsroom.
https://www.bloomberg.com/profile/company/1371288D:IM
Company profile page for Aptalis Pharma Srl including stock price, company news, press releases, executives, board members, and contact information
https://apellis.com/about-us/
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat …
Did you find the information you need about APTALIS PHARMA HEADQUARTERS?
We hope you found all the information about APTALIS PHARMA HEADQUARTERS you were looking for and more.
